ADDR 50 days' free access: Cell membrane-coated nanoparticles for targeting carcinogenic bacteria.
By Liangfang Zhang & coworkers UC San Diego
#CellMembrane #TargetedDelivery #bacteria #vaccine
authors.elsevier.com/a/1izuU_,Oflnf…

ADDR 50 days' free access: Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design.
By Sylvain Huille & coworkers Sanofi en France CRS BeNeLux & France Local Chapter
#SubcutaneousDevices #formulation #InjectionPain
authors.elsevier.com/a/1izuU,3sXTmT…

ADDR 50 days' free access: Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines.
By Dimitrios I. Zeugolis & coworkers University College Dublin UKICRS Dimitrios Zeugolis
#GeneMedicine #CornealFibrosis
doi.org/10.1016/j.addr…

ADDR in press: Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design.
By Jennifer Stevenson & coworkers Amgen 🧪🔬🧬
#SubcutaneousDelivery #BiotechIndustry
doi.org/10.1016/j.addr…

ADDR in press: Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease.
By Marlene Lúcio & coworkers Universidade Minho CRS Focus Group - Ocular Delivery
#OcularDelivery #nanocarrier #theranostic #EyeDisease
doi.org/10.1016/j.addr…

ADDR in press: Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
By Christopher M. Jewell & coworkers UMD Bioengineering
#immunotherapy #biomaterial #skin
doi.org/10.1016/j.addr…

ADDR in press: Nanoparticle-neutrophils interactions for autoimmune regulation.
By Omolola Eniola-Adefeso & coworkers Michigan Chemical Engineering
#nanoparticle #neutrophil #autoimmunity
doi.org/10.1016/j.addr…

Dr. Ick Chan Kwon's excellent review article published in Editors of Advanced Drug Delivery Reviews.

Congrats to my grad student Namratha for her first paper from our lab!

ADDR in press: Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases.
By Xinwu Cui & coworkers HUST
#FocusedUltrasound #BloodBrainBarrier #NeurodegenerativeDisease
doi.org/10.1016/j.addr…

ADDR in press: The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine.
By Sabina Pozzi & Ronit Satchi Fainaro TAU Faculty of Medical & Health Sciences Ronit Satchi-Fainaro
#nanomedicine #CCL2 #CCR2 #inflammation
doi.org/10.1016/j.addr…

ADDR 50 days' free access: A New Era of Targeting Cystic Fibrosis with Non-Viral Delivery of Genomic Medicines.
By Gaurav Sahay & coworkers Oregon State COP Gaurav Sahay
#GeneDelivery #GeneEditing #CysticFibrosis
authors.elsevier.com/a/1ixuf,3sXTmT…

Another great work published in our special issue on 'Advanced strategies to bridge the gap between inflammation and tissue regeneration', that has just been completed! take a look @ sciencedirect.com/journal/advanc…

ADDR in press: Fusobacterium nucleatum carcinogenesis and drug delivery interventions.
By Leaf Huang & coworker UNC Pharmacy
#microbiome #Fusobacterium
doi.org/10.1016/j.addr…

ADDR in press: Cell membrane-coated nanoparticles for targeting carcinogenic bacteria.
By Liangfang Zhang & coworkers UC San Diego
#CellMembrane #nanoparticle #bacteria
doi.org/10.1016/j.addr…

ADDR in press: Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines.
By Dimitrios I. Zeugolis & coworkers University College Dublin UKICRS CRS Focus Group - Ocular Delivery
#GeneTherapy #CornealFibrosis
doi.org/10.1016/j.addr…

ADDR in press: Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.
By Ick Chan Kwon & coworkers 한국과학기술연구원(KIST) CRS Korea Chapter @doubleparr
#siRNAdelivery #nanoparticle #CombinationTherapy #immunotherapy

Check it! Cool to see where fibronectin research is going. Karin Wang

ADDR 50 days' free access: Interactions between nanoparticles and lymphatic systems: mechanisms and applications in drug delivery.
By Wufa Fan & coworkers, Peking Union Medical College
#LymphaticDelivery #vaccine #ProteinCorona
authors.elsevier.com/a/1ivHg,3sXTmT…

ADDR Open Access: Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics.
By María J. Blanco Prieto & coworkers Universidad de Navarra
#RNAdelivery #CardiovasucularDisease
doi.org/10.1016/j.addr…